One evening in July of 2020, a woman named Kathryn went to the hospital in excruciating pain. A 32-year-old psychology grad student in Michigan, Kathryn lived with endometriosis, an agonizing condition that causes uterine-like cells to abnormally develop in the wrong places. Menstruation prompts these growths to shed--and, often, painfully cramp and scar, sometimes leading internal organs to adhere to one another--before the whole cycle starts again. For years, Kathryn had been managing her condition in part by taking oral opioids like Percocet when she needed them for pain. But endometriosis is progressive: Having once been rushed into emergency surgery to remove a life-threatening growth on her ovary, Kathryn now feared something just as dangerous was happening, given how badly she hurt.

Appriss Inc., a leading provider of technology, data and analytics solutions that mitigate risk, improve the quality and efficiency of patient care, and improve retail performance, announced Mr. Krishnan (Krish) Sastry's promotion to President and Chief Executive Officer. The company's founder and current President and CEO, Mr. Michael Davis, will remain engaged as its Executive Chairman. Mr. Sastry will assume the President and CEO position as of August 3rd, 2020 and will serve in his current position as Chief Operating Officer until then. Krish joined Appriss as its Executive Vice President of Products in 2013 and has held multiple senior executive positions in the company. Krish launched the Appriss Health division which is now the nation's leading platform focused on the prevention of substance use disorders (SUD) and access to care for patients with SUD and behavioral health conditions.